Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for depressive symptoms in colon cancer patients receiving chemotherapy
IRCT201508201556N79Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of celecoxib in major depressive disorder (MDD) and colon cancer, sponsored by Tehran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
celecoxib
03
Conditions
major depressive disorder (MDD)colon cancer
Beyond the preview
Go deeper on IRCT201508201556N79.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201508201556N79.